Analystreport

Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Moderna, Inc.  (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations